Drug makers’ input costs almost double amid weak naira

Nigeria’s drug makers are battling with a rising input cost amid still sky-high inflation and weak naira that have seen their costs almost double in one year, an analysis by BusinessDay has shown. Four of Nigeria’s listed drug makers saw their combined cost of sales surge from N15.5 billion